ubs glp-1 sales forecast Market Size, Scope, Report 2026 to 2035 GLP-1 Receptor Agonist Market Growth
Description
Hung, S
[4] Liver enzymes (ALT, AST): While GLP-1medications are not known to cause liver injury and are generally safe in people without advanced liver disease, baseline liver tests may be obtained to evaluate overall metabolic health
Some people experience persistent fatigue , headaches , or anxiety that does not resolve with dose adjustments
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Have tried liraglutide or semaglutide without satisfactory results
